Cargando…
Development and characterization of protein kinase B/AKT isoform-specific nanobodies
The serine/threonine protein kinase AKT is frequently over-activated in cancer and is associated with poor prognosis. As a central node in the PI3K/AKT/mTOR pathway, which regulates various processes considered to be hallmarks of cancer, this kinase has become a prime target for cancer therapy. Howe...
Autores principales: | Merckaert, Tijs, Zwaenepoel, Olivier, Gevaert, Kris, Gettemans, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549812/ https://www.ncbi.nlm.nih.gov/pubmed/33045011 http://dx.doi.org/10.1371/journal.pone.0240554 |
Ejemplares similares
-
VCA nanobodies target N-WASp to reduce invadopodium formation and functioning
por: Hebbrecht, Tim, et al.
Publicado: (2017) -
Triazolinedione protein modification: from an overlooked off-target effect to a tryptophan-based bioconjugation strategy
por: Decoene, Klaas W., et al.
Publicado: (2022) -
A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis
por: Van Impe, Katrien, et al.
Publicado: (2013) -
A nanobody modulates the p53 transcriptional program without perturbing its functional architecture
por: Bethuyne, Jonas, et al.
Publicado: (2014) -
Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer
por: Van Audenhove, Isabel, et al.
Publicado: (2016)